AngioDynamics
ANGO
174 hedge funds and large institutions have $747M invested in AngioDynamics in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 58 increasing their positions, 67 reducing their positions, and 24 closing their positions.
0.88% less ownership
Funds ownership: 100.84% → 99.96% (-0.88%)
8% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 24
2% less funds holding
Funds holding: 177 → 174 (-3)
8% less capital invested
Capital invested by funds: $813M → $747M (-$65.9M)
13% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 67
79% less call options, than puts
Call options by funds: $105K | Put options by funds: $503K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$19.1M |
| 2 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$3.79M |
| 3 |
BlackRock
New York
|
+$3.29M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.59M |
| 5 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$2.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$6.28M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$5.21M |
| 3 |
Man Group
London,
United Kingdom
|
-$4.79M |
| 4 |
Millennium Management
New York
|
-$3.56M |
| 5 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
-$3.49M |
ANGO Hedge Fund Activity: Q4 2018 in Review
174 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2018, worth a combined $747M — down 8.1% from $813M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of ANGO and 22 opened new positions — a net loss of 2 holders — while 67 trimmed existing stakes and 58 added.
The largest buyer was Victory Capital Management, adding an estimated $19.1M. The largest seller was Broadfin Capital, exiting entirely with an estimated $6.28M sold.
- 174 institutional investors held AngioDynamics (ANGO) as of Q4 2018, down from 177 in Q3 2018.
- Funds reported $747M of AngioDynamics stock for Q4 2018, down 8.1% quarter-over-quarter.
- 22 funds opened new AngioDynamics positions in Q4 2018 and 24 closed out, a net change of -2 holders.
- The largest AngioDynamics buyer in Q4 2018 was Victory Capital Management, an estimated $19.1M added.
- The largest AngioDynamics seller in Q4 2018 was Broadfin Capital, an estimated $6.28M sold.
Based on aggregated 13F filings for Q4 2018.